Organ Preservation in Rectal Cancer by Dose Escalated MR Guided Adaptive Radiotherapy
NCT07337876
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Rectal Cancer
Interventions
RADIATION:
Dose escalated radiotherapy using a 1.5 T MR-Linac
Sponsor
University Hospital Tuebingen